These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7878646)

  • 1. Crossreactivity studies between sera of patients with heparin associated thrombocytopenia and a new low molecular weight heparin, reviparin.
    Greinacher A; Feigl M; Mueller-Eckhardt C
    Thromb Haemost; 1994 Oct; 72(4):644-5. PubMed ID: 7878646
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Shih FF; Porche-Sorbet R; Eby C; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):251-60. PubMed ID: 20460351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies.
    Shoenfeld Y
    Isr J Med Sci; 1997 Apr; 33(4):243-5. PubMed ID: 9347871
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
    Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
    Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin-induced thrombocytopenia and crossreactivity study between anti-heparin/platelet factor 4 -antibody and low molecular weight heparin].
    Wang JH; Wang CY; Chen X
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):584-6. PubMed ID: 22967427
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia.
    Weimann G; Lubenow N; Selleng K; Eichler P; Albrecht D; Greinacher A
    Eur J Haematol; 2001 Mar; 66(3):195-9. PubMed ID: 11350488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-associated thrombocytopenia: the antibody is not heparin specific.
    Greinacher A; Michels I; Mueller-Eckhardt C
    Thromb Haemost; 1992 May; 67(5):545-9. PubMed ID: 1325681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between platelet factor 4/heparin complexes ELISA and platelet aggregation test in heparin-induced thrombocytopenia.
    Nguyên P; Droullé C; Potron G
    Thromb Haemost; 1995 Aug; 74(2):804-5. PubMed ID: 8585032
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: diagnosis and management.
    Warkentin TE
    Circulation; 2004 Nov; 110(18):e454-8. PubMed ID: 15520327
    [No Abstract]   [Full Text] [Related]  

  • 11. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia.
    Greinacher A; Michels I; Kiefel V; Mueller-Eckhardt C
    Thromb Haemost; 1991 Dec; 66(6):734-6. PubMed ID: 1796420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopenia.
    Mims MP; Manian P; Rice L
    Eur J Haematol; 2004 May; 72(5):366-9. PubMed ID: 15059074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 14. Report of a patient with heparin-induced thrombocytopenia type II associated with IgA antibodies only.
    Meyer O; Aslan T; Koster A; Kiesewetter H; Salama A
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):373-5. PubMed ID: 16959694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.
    Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C
    Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which patients undergoing cardiopulmonary bypass should be assessed for development of heparin-induced thrombocytopenia?
    Cummins D; Halil O; Amin S
    Thromb Haemost; 1995 May; 73(5):890. PubMed ID: 7482421
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved laboratory confirmation of heparin-induced thrombocytopenia type II. Time course of antibodies and combination of antigen and biologic assays.
    Harenberg J; Wang L; Hoffmann U; Huhle G; Feuring M
    Am J Clin Pathol; 2001 Mar; 115(3):432-8. PubMed ID: 11242800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia.
    Amiral J; Lormeau JC; Marfaing-Koka A; Vissac AM; Wolf M; Boyer-Neumann C; Tardy B; Herbert JM; Meyer D
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):114-7. PubMed ID: 9518042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.